Electronic Medicinal Product Information (ePI) FHIR Implementation Guide
1.0.0-ballot - STU Ballot International flag

This page is part of the Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR v5.0.0-ballot. . For a full list of available versions, see the Directory of published versions

Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Behavior: Capability Statements

The following artifacts define the specific capabilities that different types of systems are expected to have in order to comply with this implementation guide. Systems conforming to this implementation guide are expected to declare conformance to one or more of the following capability statements.

epi-server

This section describes a minumum expected capabilities of an ePI FHIR Server which is responsible for providing responses to the queries submitted by the ePI clients. Please refer to the XML or JSON versions of this specification for details on which elements search is to be enabled on. A compliant server SHALL adhere to the requirements listed in this resource, and implement the RESTful behavior according to the FHIR specification.

Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

AdministrableProductDefinition (ePI)

AdministrableProductDefinition (ePI)

Bundle - ePI

Medicinal product information is a pivotal source of regulated and scientifically validated information that assists healthcare professionals in prescribing and dispensing the medicine and informs consumers about its safe and effective use. This profile represents the constraints applied to the Bundle resource used in the Electronic Product Information (ePI) FHIR Implementation Guide.

ClinicalUseDefinition Contraindication (ePI)

ClinicalUseDefinition Contraindication (ePI)

ClinicalUseDefinition Indication (ePI)

ClinicalUseDefinition Indication (ePI)

ClinicalUseDefinition Interaction (ePI)

ClinicalUseDefinition Interaction (ePI)

ClinicalUseDefinition Undesirable Effect (ePI)

ClinicalUseDefinition Undesirable Effect (ePI)

ClinicalUseDefinition Warning (ePI)

ClinicalUseDefinition Warning (ePI)

Composition (ePI)

The Composition captures the section headings, sub-section headings, and narrative text (For example, paragraphs, bulleted lists, tables) in an ePI.

Ingredient (ePI)

Ingredient (ePI)

ManufacturedItemDefinition (ePI)

ManufacturedItemDefinition (ePI)

MedicinalProductDefinition (ePI)

Description of the packaged authorized medicinal product(s) associated to this ePI document.

Organization (ePI)

Organization (ePI)

PackagedProductDefinition (ePI)

PackagedProductDefinition (ePI)

RegulatedAuthorization (ePI)

RegulatedAuthorization (ePI)

SubstanceDefinition (ePI)

SubstanceDefinition (ePI)

Terminology: Value Sets

These define sets of codes used by systems conforming to this implementation guide.

Additional Monitoring Indicator

Additional Monitoring Indicator

AdministrableProductDefinition identifier systems

AdministrableProductDefinition Identifier systems (uri)

WHO ATC

World Health Organization Anatomical Therapeutic Chemical (ATC) classification system

Authorization Status

Authorization Status

Case System Identifiers

Case System Identifiers

ISO Country two letter code

ISO Country two letter code

Data Carrier Identifiers

Listing of identifiers for Data Carriers

ePI document types

ePI document types

The topic of this list

The topic of this list

General Status used across ePI resources

General Status used across ePI resources

Legal Status for the Supply

Legal Status for the Supply

ManufacturedItemDefinition identifier systems

ManufacturedItemDefinition Identifier systems (uri)

Marketing Status

Marketing Status

MedicinalProductDefinition identifier systems

MedicinalProductDefinition Identifier systems (uri)

Medicinal Product Type

Medicinal Product Type

MedDRA Terms for clinical diseases and symptoms

MedDRA Terms for clinical diseases and symptoms

Non-proprietary Name of the active ingredient(s)

Non-proprietary Name of the active ingredient(s)

Type of operation

Type of operation

Organization identifier systems

Organization Identifier systems (uri)

Type of organization

Type of organization

Package Material

Package Material

High level Pack Type

High level type of pack; e.g., medicinal product pack, sample pack, shipping container.

PackagedProductDefinition identifier systems

PackagedProductDefinition Identifier systems (uri)

Part Type

Part Type

Pediatric Use Indicator

Pediatric Use Indicator

Combined Pharmaceutical Dose Form

Combined Pharmaceutical Dose Form

Pharmaceutical Dose Form of the medicinal product

Pharmaceutical Dose Form of the medicinal product

Product Confidentiality

Product Confidentiality

Product Name Part Type

Product Name Part Type

Color of the product

Color of the product

Flavor of the product

Flavor of the product

Score on the product

Score on the product

Shape of the product

Shape of the product

Surface form of the product

Surface form of the product

Proprietary Name of the medicinal product

Proprietary Name of the medicinal product

Type of Regulated Authorization

Type of Regulated Authorization

Regulated Authorization Type identifier systems

Regulated Authorization Type Identifier systems (uri)

Regulatory Activity Type

Regulatory Activity Type; e.g., MAA

Ingredient Role; e.g., inactive, active base, active moiety

Ingredient Role; e.g., inactive, active base, active moiety

Route Of Administration

Route Of Administration

Pack Type

Pack Type

Section Codes

Section Codes

Shelf Life Type

Shelf Life Type

Special Precautions For Storage

Special Precautions For Storage

Strength of the medicinal product name

Strength of the medicinal product name

Substances

Substances

Units of Measure

Units of Measure

Units of Presentation

Units of Presentation

Terminology: Code Systems

These define new code systems used by systems conforming to this implementation guide.

eMedicinal Product Information Code System

eMedicinal Product Information Code System. Coded concepts defined for internal project use.

Organization Management Services CodeSystem

Items from https://spor.ema.europa.eu/omswi

Products Management Services CodeSystem

Items from https://spor.ema.europa.eu/pmswi

Referentials Management Services CodeSystem

Items from https://spor.ema.europa.eu/rmswi

Substances Management Services CodeSystem

Items from https://spor.ema.europa.eu/smswi

Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

Ingredient-excipient Silicon dioxide

Silicon dioxide

Ingredient-excipient Hypromellose

Hypromellose

Ingredient-excipient Microcrystalline cellulose

Microcrystalline cellulose

Regulated Authorization for cava 75 mg tablets

Regulated Authorization

Manufactured item cava 75 mg tabelt

cava 75 mg tablet

cava 75mg tablet administrable product

cava 75 mg tablet

indication

Indication

Irbesartan – Example of Ingredient with basis for strength

irbesartan

Ingredient-excipient Lactose Monohydrate

Lactose Monohydrate

Medicinal Product cava 75 mg tablet in blister pack of 28 tablets

EU/1/97/049/001 cava 75 mg tablet blister x28

contraindication

Contraindication - Gastrointestinal disorders

Ingredient-excipient carnauba wax

Carnauba wax

Ingredient-excipient Titanium Dioxide

Titanium Dioxide

warninghypotension

Warning - hypotension

ePI document Bundle for cava 75 mg Package Leaflet

Bundle for cava Package Leaflet ePI document

Ingredient-excipient Macrogol 3000

Macrogol 3000

Acme Inc. as Marketing Authorization Holder

Marketing Authorization Holder

substanceirbesartan

irbesartan

interactionmethotrexate

Interaction - METHOTREXATE

Composition for cava 75 mg Package Leaflet

Package Leaflet

Packaging Blister x28 75 mg tablets

Blister x28 tablets

Ingredient-excipient Magnesium stearate

Magnesium stearate

interactiongrapefruitjuice

Interaction - GRAPEFRUIT JUICE

Ingredient-excipient Croscarmellose sodium

Croscarmellose sodium

undesirableEffectanemia

Undesirable Effect - anemia